MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 26, 2008; DOI: 10.1124/mol.108.045153


0026-895X/08/7403-904-912$20.00
Mol Pharmacol 74:904-912, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.108.045153v1
74/3/904    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mich, P. M.
Right arrow Articles by Horne, W. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mich, P. M.
Right arrow Articles by Horne, W. A.

Alternative Splicing of the Ca2+ Channel β4 Subunit Confers Specificity for Gabapentin Inhibition of Cav2.1 Trafficking

Patrice M. Mich, and William A. Horne

Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado (P.M.M.); and Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York (W.A.H.)

Gabapentin is well established as an effective treatment for neuropathic pain; however, little is known about its mechanism of action. It binds with high affinity to Ca2+ channel {alpha}2{delta} subunits that are expressed in dorsal root ganglia. Mutation of a single {alpha}2{delta} amino acid, R217A, eliminates both gabapentin binding and analgesic efficacy. Gabapentin does not seem to have direct Ca2+ channel blocking properties but does affect overall levels of Ca2+ channel surface expression in some circumstances. In this report, we examined gabapentin effects on trafficking and voltage-dependent gating properties of recombinant Cav2.1 Ca2+ channel complexes transiently expressed in Xenopus laevis oocytes. We also determined electrophysiologically whether gabapentin causes displacement of β subunits from Cav2.1 complexes. Our principal findings are as follows: 1) gabapentin inhibits trafficking of recombinant Cav2.1 Ca2+ channels in X. laevis oocytes; 2) gabapentin inhibition occurs in the presence of the Ca2+ channel β4a subunit but not in the presence of β4b; 3) gabapentin does not affect Cav2.1 voltage-dependent gating parameters; 4) inhibition of Cav2.1trafficking is highly dependent on β-subunit concentration; and 5) gabapentin inhibition of Cav2.1 trafficking can be reversed by the {alpha}2{delta} R217A mutation. Overall, our results suggest that gabapentin reduces the number of β4a-bound Cav2.1 complexes that are successfully trafficked to the plasma membrane. This mechanism may help to explain why gabapentin is both effective and selective in the treatment of neuropathic pain states that involve up-regulation of {alpha}2{delta} subunits.


Received January 10, 2008; accepted June 26, 2008

Address correspondence to: William A. Horne, T8 016A, Box 34, Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14850. E-mail: wah27{at}cornell.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics